Loading insider details...
Latest Form 4 (Oct 6, 2026): Exercise/Conversion of 10,522 ETON shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Exercise/Conversion | 10,522 | n/a |
| Aug 24, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Exercise/Conversion | 25,000 | $182.8K |
| Aug 4, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Grant/Award | 128,985 | n/a |
| Jul 13, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Exercise/Conversion | 10,000 | n/a |
| Jun 30, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Grant/Award | 10,000 | n/a |
| May 27, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Exercise/Conversion | 30,591 | $109.5K |
| Jan 14, 2026 | Eton Pharmaceuticals, Inc. (ETON) | Tax Withholding | 1,942 | $30.3K |
| Dec 12, 2025 | Eton Pharmaceuticals, Inc. (ETON) | Tax Withholding | 6,264 | $106.5K |
| Jun 16, 2025 | Eton Pharmaceuticals, Inc. (ETON) | Sale | 16,977 | $253.3K |
| Jan 6, 2025 | Eton Pharmaceuticals, Inc. (ETON) | Grant/Award | 38,621 | n/a |